Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQCommunication ServicesAdvertising AgenciesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.38 → 1.38 EPS · FY ending Dec 31, 2027 · 8 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 8; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MGNI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA margin at least 35.5% | Profit margin aims to rise to at least 35.5%. | Intact | Adjusted EBITDA margin falls below 35.5% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “|| (5) | Free cash flow is defined as operating cash flow (Adjusted EBITDA less capital expenditures) less net interest expense.” “|| (5) | Free cash flow is defined as operating cash flow (Adjusted EBITDA less capital expenditures) less net interest expense.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth-oriented advertising technology business, with recent financial performance in the stronger half of its industry. Its long-term thesis is intact, but earnings quality is fragile and risk is elevated, so execution needs to keep supporting the growth story.
Valuation is expensive relative to peers, with a 1.74 premium measure, and the valuation score recently rose from 26.0 to 36.6. The evidence points to a stretched setup and some positive expectations, but the estimated expectations gap is 0.22 and model confidence is low, so the precise degree of optimism is uncertain.
Near term, management’s stated growth priorities are showing progress: Contribution ex-TAC and CTV contribution grew year over year, while full-year margin and free-cash-flow growth guidance improved. The main near-term risks are a possible guidance cut, weakening earnings surprises, and a sector backdrop marked as a headwind; a CFO transition is also among the recent events.
Over the next few quarters, the thesis depends on continued growth in CTV and Contribution ex-TAC, and on sustaining the improved margin and cash-flow outlook. A guidance cut would challenge execution, while Fed rate cuts or continued strength from sector bellwethers could provide a more supportive backdrop.
For the next 1 to 3 years, MGNI has a credible growth and profitability story, but the expensive valuation leaves less room for weak execution. The thesis remains intact, with medium confidence, and hinges on delivery against guidance in a sector facing headwinds. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Contribution ex-TAC attributable to DV+ $87M-$89M | A primary condition in Magnite, Inc.'s published investment case. The stated target is $87M-$89M. | Intact | Contribution ex-TAC attributable to DV+ falls below $87M in Q2 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Free cash flow growth in mid 30% range | Free cash flow growth targets the mid 30% range. | Improving | Free cash flow growth falls below 30% in FY26 | Free cash flow growth: 7,112.26% FY2026-Q2; GAAP. Published target: mid 30% growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 5, 20267,112.262242 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “|| (5) | Free cash flow is defined as operating cash flow (Adjusted EBITDA less capital expenditures) less net interest expense.” “|| (3) | Operating cash flow is calculated as Adjusted EBITDA less capital expenditures.” Delivery assessment Nov 5, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.24 → $1.38 · observed estimates
$0.82B → $0.84B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.24 | $821,396,192 | 8 / 7 |
| 2026-07-25 | $1.24 | $815,170,400 | 10 / 10 |
| 2026-07-26 | $1.24 | $815,170,400 | 10 / 10 |
| 2026-07-27 | $1.24 | $821,396,192 | 8 / 7 |
| 2026-07-28 | $1.24 | $815,170,400 | 10 / 10 |
| 2026-07-29 | $1.24 | $815,170,400 | 10 / 10 |
| 2026-07-30 | $1.24 | $816,160,400 | 10 / 10 |
| 2026-07-31 | $1.24 | $816,160,400 | 10 / 10 |
| 2026-08-01 | $1.24 | $821,434,038 | 8 / 7 |
| 2026-08-02 | $1.24 | $816,160,400 | 10 / 10 |
| 2026-08-03 | $1.24 | $816,160,400 | 10 / 10 |
| 2026-08-04 | $1.24 | $821,434,038 | 8 / 7 |
| 2026-08-05 | $1.24 | $816,160,400 | 10 / 10 |
| 2026-08-06 | $1.24 | $820,860,400 | 10 / 10 |
| 2026-08-07 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-08 | $1.28 | $835,853,500 | 10 / 10 |
| 2026-08-09 | $1.28 | $835,853,500 | 10 / 10 |
| 2026-08-10 | $1.28 | $835,853,500 | 10 / 10 |
| 2026-08-12 | $1.29 | $838,146,500 | 10 / 10 |
| 2026-08-13 | $1.29 | $838,146,500 | 10 / 10 |
| 2026-08-14 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-15 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-16 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-17 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-18 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-19 | $1.32 | $834,416,538 | 8 / 7 |
| 2026-08-20 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-21 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-22 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-23 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-24 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-25 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-26 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-27 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-28 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-29 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-30 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-08-31 | $1.34 | $841,514,923 | 8 / 7 |
| 2026-09-01 | $1.34 | $841,487,808 | 8 / 7 |
| 2026-09-02 | $1.34 | $841,487,808 | 8 / 7 |
| 2026-09-03 | $1.34 | $841,487,808 | 8 / 7 |
| 2026-09-04 | $1.34 | $841,487,808 | 8 / 7 |
| 2026-09-05 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-06 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-07 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-08 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-09 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-10 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-11 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-12 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-13 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-14 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-15 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-16 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-17 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-18 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-19 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-20 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-21 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-22 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-23 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-24 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-25 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-26 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-27 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-28 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-29 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-09-30 | $1.34 | $841,647,038 | 8 / 7 |
| 2026-10-01 | $1.38 | $841,647,038 | 8 / 7 |
| 2026-10-02 | $1.38 | $841,647,038 | 8 / 7 |
| 2026-10-03 | $1.38 | $841,647,038 | 8 / 7 |
| 2026-10-04 | $1.38 | $841,647,038 | 8 / 7 |
| 2026-10-05 | $1.38 | $841,647,038 | 8 / 7 |
| 2026-10-06 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-07 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-08 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-09 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-10 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-11 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-12 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-13 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-14 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-15 | $1.38 | $843,339,346 | 8 / 7 |
| 2026-10-16 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-17 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-18 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-19 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-20 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-21 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-22 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-23 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-24 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-25 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-26 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-27 | $1.38 | $843,366,462 | 8 / 7 |
| 2026-10-28 | $1.38 | $843,403,077 | 8 / 7 |
| 2026-10-29 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-10-30 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-10-31 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-11-01 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-11-02 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-11-03 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-11-04 | $1.38 | $843,526,154 | 8 / 7 |
| 2026-11-05 | $1.38 | $843,526,154 | 8 / 7 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 13 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 3 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.